{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["28(11)"],"submitter":["Nguyen NN"],"pubmed_abstract":["We describe 188 patients in France who were successively infected with different SARS-CoV-2 Omicron subvariants, including BA.1, BA.2, and BA.5. Time between 2 infections was <90 days for 50 (26.6%) patients and <60 days for 28 (14.9%) patients. This finding suggests that definitions for SARS-CoV-2 reinfection require revision."],"journal":["Emerging infectious diseases"],"pagination":["2341-2343"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9622229"],"repository":["biostudies-literature"],"pubmed_title":["Reinfections with Different SARS-CoV-2 Omicron Subvariants, France."],"pmcid":["PMC9622229"],"pubmed_authors":["Nguyen NN","Colson P","Gautret P","Delorme L","Houhamdi L"],"additional_accession":[]},"is_claimable":false,"name":"Reinfections with Different SARS-CoV-2 Omicron Subvariants, France.","description":"We describe 188 patients in France who were successively infected with different SARS-CoV-2 Omicron subvariants, including BA.1, BA.2, and BA.5. Time between 2 infections was <90 days for 50 (26.6%) patients and <60 days for 28 (14.9%) patients. This finding suggests that definitions for SARS-CoV-2 reinfection require revision.","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Nov","modification":"2025-04-04T07:45:19.844Z","creation":"2025-04-04T07:45:19.844Z"},"accession":"S-EPMC9622229","cross_references":{"pubmed":["36150518"],"doi":["10.3201/eid2811.221109"]}}